Table 1 Demographic and clinical characteristics of the participants
Characteristics | Entire cohort | p | |
|---|---|---|---|
COVID-19 Positive (n = 328) | COVID-19 Negative (n = 75) | ||
Age | 57.57 ± 11.42 | 57.82 ± 11.10 | 0.501 |
Female,n(%) | 89 (27.1) | 24 (32.0) | 0.482 |
BMI | 25.57 ± 7.75 | 24.92 ± 3.48 | 0.479 |
Hypertension | 173 (52.7) | 30 (40.0) | 0.062 |
Diabetes mellitus | 96 (29.3) | 13 (17.3) | 0.036 |
Hyperlipidemia | 115 (35.1) | 13 (17.3) | 0.005 |
COPD | 5 (1.5) | 0 | 0.619 |
Peripheral vascular disease | 15 (4.6) | 3 (4.0) | NA |
Cerebrovascular events | 47 (14.3) | 11 (14.7) | NA |
Myocardial infarction | 45 (13.7) | 12 (16.0) | 0.743 |
Chronic heart failure | 21 (6.4) | 1 (1.3) | 0.144 |
Creatinine | 84.94 ± 70.18 | 85.28 ± 67.47 | 0.383 |
Ejection fraction | 58.20 (8.64) | 56.97 (9.30) | 0.277 |
NYHA class | 0.936 | ||
I | 111 (33.8) | 27 (36.0) | |
II | 206 (62.8) | 45 (60.0) | |
III | 11 (3.3) | 3 (4.0) | |
Surgery type | 0.102 | ||
CABG | 191(58.2) | 51(68.0) | |
CABG + valvular surgery | 17(5.2) | 0(0) | |
Valvular surgery | 66(20.1) | 9(12.0) | |
Aortic dissection repair | 29(8.8) | 7(9.3) | |
Other | 25(7.6) | 8(10.7) | |